Results
26
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
26 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
UZU | €48.40 | 3.0% | 8.5% | €242.1m | €64.00 | PE10.2x | E2.1% | 3.3% | ||
EIS | €11.50 | 0.9% | 8.5% | €200.6m | n/a | PE18.5x | n/a | 5.2% | ||
WCH | €72.06 | -2.4% | -36.3% | €3.6b | €114.87 | PE28.8x | E37.0% | 4.2% | ||
NDA | €76.70 | -0.4% | -0.08% | €3.5b | €70.70 | PE9x | E-6.2% | 1.8% | ||
ACT | €59.80 | 8.3% | 158.9% | €608.5m | €72.05 | PE12.1x | E12.6% | 2.0% | ||
NTG | €13.90 | 0.7% | -10.9% | €122.3m | €22.50 | PE9.1x | E5.7% | 2.0% | ||
DLX | €2.38 | 0% | -42.2% | €24.4m | €6.60 | PE12.5x | E25.1% | 3.4% | ||
BNN | €3.17 | 8.2% | -14.3% | €69.5m | €6.30 | PS1.2x | E71.5% | n/a | ||
SIM0 | €59.00 | 3.5% | -15.7% | €339.0m | n/a | PE11.4x | n/a | 3.1% | ||
EVK | €17.38 | -2.3% | -0.7% | €8.1b | €22.31 | PE35.4x | E33.1% | 6.7% | ||
HEI | €118.30 | -0.4% | 64.1% | €21.1b | €122.79 | PE11.4x | E7.8% | 2.5% | ||
IBU | €7.06 | -14.9% | -66.2% | €34.7m | €12.00 | PS0.7x | E109.4% | 0.6% | ||
2NF | €71.16 | -5.9% | n/a | €7.6b | n/a | PS1.1x | E39.3% | 2.3% | ||
1COV | €57.32 | 0.3% | 20.9% | €10.8b | €60.92 | PS0.8x | E62.2% | 0% | ||
2HRA | €3.28 | -3.2% | -31.2% | €122.1m | €5.70 | PE12.8x | E34.4% | 3.0% | ||
SZG | €17.12 | -4.0% | -38.9% | €940.6m | €18.97 | PS0.09x | E93.9% | 2.6% | ||
TKA | €3.88 | 18.6% | -45.1% | €2.4b | €5.18 | PS0.07x | E117.7% | 3.9% | ||
M0LY | €0.53 | 10.4% | 61.6% | €62.7m | n/a | PB42.7x | n/a | n/a | ||
AMA | €2.52 | 0% | -76.9% | €19.0m | n/a | PS174.2x | n/a | n/a | ||
BAS | €42.37 | 0.4% | -3.1% | €37.8b | €53.38 | PE76.1x | E34.2% | 8.0% | ||
M1Q1 New | €0.0005 | 0% | -88.9% | €336.6k | n/a | PB0.4x | n/a | n/a | ||
NSAK | €0.055 | -19.1% | n/a | €571.0k | n/a | PS0.03x | n/a | n/a | ||
SDF | €11.25 | 2.9% | -22.9% | €2.0b | €11.48 | PE78.7x | E61.1% | 6.2% | ||
SY1 | €104.25 | -0.1% | 2.1% | €14.4b | €120.61 | PE37.1x | E13.2% | 1.1% |